Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01877811
Title	CEP-32496 in Patients With Advanced Solid Tumors in Phase 1 and Advanced Melanoma and Metastatic Colorectal Cancer in Phase 2
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Teva Pharmaceutical Industries
Indications	lung squamous cell carcinoma lung adenocarcinoma Advanced Solid Tumor
Therapies	RXDX-105
Age Groups:	adult \| senior
Covered Countries	USA